Co-Diagnostics Inc (FRA:C97)
€ 1.14 -0.02 (-1.72%) Market Cap: 36.13 Mil Enterprise Value: -1.88 Mil PE Ratio: 0 PB Ratio: 0.56 GF Score: 51/100

Q2 2023 Co-Diagnostics Inc Earnings Call Transcript

Aug 10, 2023 / 08:30PM GMT
Release Date Price: €1.25 (+1.95%)
Operator

Welcome to the Co-Diagnostics Second Quarter 2023 Earnings Conference Call. (Operator Instructions) Please note that this event is being recorded.

I would now like to turn the conference over to Andrew Benson, Head of Investor Relations. Please go ahead.

Andrew Benson
Co-Diagnostics, Inc. - Head of IR

Thank you. Good afternoon, everyone, and thank you for participating in today's conference call. On the call from Co-Diagnostics, we have Dwight Egan, Chief Executive Officer; and Brian Brown, Chief Financial Officer.

Earlier today, Co-Diagnostics released financial results from the second quarter ended June 30, 2023. A copy of the press release is available on the company's website. We will begin the call with management's prepared remarks and then open up the call to analyst Q&A.

Before we begin, we would like to inform the listeners that certain statements made by Co-Diagnostics during this call may constitute forward-looking statements. Any statement about company expectations, beliefs, plans, objectives, assumptions of future

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot